Relaxin as a cardiovascular hormone: physiology, pathophysiology and therapeutic promises.
about
Role of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxinRelaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling.Cellular retrograde cardiomyoplasty and relaxin therapy for postischemic myocardial repair in a rat modelProtection from cigarette smoke-induced vascular injury by recombinant human relaxin-2 (serelaxin)Relaxin as a natural agent for vascular healthRelaxin and its role in the development and treatment of fibrosis.Relaxin: a novel agent for the treatment of acute heart failure.Functional and histopathological improvement of the post-infarcted rat heart upon myoblast cell grafting and relaxin therapy.Relaxin promotes growth and maturation of mouse neonatal cardiomyocytes in vitro: clues for cardiac regeneration.Identification of recombinant human relaxin-2 in equine plasma by liquid chromatography-high resolution mass spectrometry.Pretreatment with Relaxin Does Not Restore NO-Mediated Modulation of Calcium Signal in Coronary Endothelial Cells Isolated from Spontaneously Hypertensive Rats.Identification of porcine relaxin in plasma by liquid chromatography-high resolution mass spectrometry.RXFP1 Receptor Activation by Relaxin-2 Induces Vascular Relaxation in Mice a Gα-Protein/PI3Kß/γ/Nitric Oxide-Coupled Pathway
P2860
Q33631848-FCF5C120-C968-4EBF-A2BC-0E6561897D59Q34398874-C4DCB128-89DC-48C7-AD43-A53B4412B2D4Q34737733-A2FBAF18-7D74-4A8C-8133-C0ABCB616F3EQ36176574-5F57B5E2-C88C-4B32-A46D-DB87277FBA7EQ36797528-27FB74E3-33FE-4388-9DA8-749524D38411Q36835818-DB57034B-5D59-4392-AEB6-9265CA426C8EQ37229308-D8687BE1-5028-49FE-8AAE-FE17FC6F6007Q38373223-F473A3B9-E3C1-446A-97DC-6905B046692CQ42079587-D54DF863-91BB-4089-9BC6-B84B880CC7E0Q42914480-73414F0F-EECD-4130-A675-7BF996BFE348Q45718465-A5671F45-E097-43F4-8E6E-73DB80F38EB6Q53491732-D939DE2C-7E14-475C-94A2-7F1C2CC78119Q53545050-D20E3591-F9F2-47F8-8DB3-B809EDBEF431Q58764679-A19E5121-39E0-4C59-8D12-7533987B1A7A
P2860
Relaxin as a cardiovascular hormone: physiology, pathophysiology and therapeutic promises.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Relaxin as a cardiovascular ho ...... logy and therapeutic promises.
@ast
Relaxin as a cardiovascular ho ...... logy and therapeutic promises.
@en
Relaxin as a cardiovascular ho ...... logy and therapeutic promises.
@nl
type
label
Relaxin as a cardiovascular ho ...... logy and therapeutic promises.
@ast
Relaxin as a cardiovascular ho ...... logy and therapeutic promises.
@en
Relaxin as a cardiovascular ho ...... logy and therapeutic promises.
@nl
prefLabel
Relaxin as a cardiovascular ho ...... logy and therapeutic promises.
@ast
Relaxin as a cardiovascular ho ...... logy and therapeutic promises.
@en
Relaxin as a cardiovascular ho ...... logy and therapeutic promises.
@nl
P2093
P1476
Relaxin as a cardiovascular ho ...... logy and therapeutic promises.
@en
P2093
Daniele Bani
Mario Bigazzi
Silvia Nistri
P304
P356
10.2174/187152507780363179
P577
2007-04-01T00:00:00Z